ÂÜÀòÂÒÂ×

Roy Wallen is an experienced leader in healthcare technology commercialization, currently serving as Executive in Residence at the Advanced Regenerative Manufacturing Institute (ARMI) | BioFabUSA. Wallen's extensive career includes pivotal roles such as President & CEO of Directional Healthcare Advisors, where advisory services focus on early-stage healthcare technology companies. Previously, Wallen held senior positions at Pristine Surgical, including Vice President of Quality and Regulatory, Chief Product Officer, and General Manager of New Markets. Additional experience includes leadership at TendoNova, Thermo Fisher Scientific, and directing product development at Abiomed, Inc., and Edwards Lifesciences LLC. Wallen's education includes a BS in Electrical Engineering from Northeastern University and further studies at Stanford University.